| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 89bio, Inc. | Chief Operating Officer | Common Stock | 0 | $0 | $14.70 | 30 Oct 2025 | Direct |
| 89bio, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 0 | 30 Oct 2025 | Direct | ||
| Apexigen, Inc. | President and COO | Common Stock | 0 | $0.3851 | 23 Aug 2023 | Direct | |
| Apexigen, Inc. | President and COO | Employee Stock Option (right to buy) | 0 | 23 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ETNB | 89bio, Inc. | 30 Oct 2025 | 3 | $0 | 4 | Chief Operating Officer | 30 Oct 2025, 20:10 |
| ETNB | 89bio, Inc. | 01 Aug 2025 | 2 | -$58,233 | 4 | Chief Operating Officer | 05 Aug 2025, 20:10 |
| ETNB | 89bio, Inc. | 01 Feb 2025 | 2 | $0 | 4 | Chief Operating Officer | 04 Feb 2025, 21:29 |
| ETNB | 89bio, Inc. | 05 Aug 2024 | 2 | $0 | 4 | Chief Operating Officer | 07 Aug 2024, 18:05 |
| ETNB | 89bio, Inc. | 30 Jul 2024 | 0 | $0 | 3 | Chief Operating Officer | 07 Aug 2024, 18:00 |
| /report/000120919123047439-sarena-francis-willard-2023-08-23 | Apexigen, Inc. | 23 Aug 2023 | 3 | -$11,985 | 4 | President and COO | 25 Aug 2023, 20:17 |
| /report/000120919123039495-sarena-francis-willard-2023-06-15 | Apexigen, Inc. | 15 Jun 2023 | 1 | -$3,397 | 4 | President and COO | 23 Jun 2023, 17:54 |
| /report/000120919123032162-sarena-francis-willard-2023-05-23 | Apexigen, Inc. | 23 May 2023 | 2 | -$8,299 | 4 | President and COO | 25 May 2023, 16:18 |
| /report/000120919122062004-sarena-francis-willard-2022-12-15 | Apexigen, Inc. | 15 Dec 2022 | 1 | -$7,331 | 4 | Chief Operating Officer | 19 Dec 2022, 16:49 |
| /report/000120919122053349-sarena-francis-willard-2022-10-07 | Apexigen, Inc. | 07 Oct 2022 | 1 | $0 | 4 | Chief Operating Officer | 11 Oct 2022, 16:56 |
| /report/000120919122044832-sarena-francis-willard-2022-07-29 | Apexigen, Inc. | 29 Jul 2022 | 0 | $0 | 3 | Chief Operating Officer | 08 Aug 2022, 16:58 |